| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173440A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
| 01/23/2002 | EP1173204A1 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/23/2002 | EP1173202A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 01/23/2002 | EP1173201A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP1173183A2 Use of compounds with a nitrogen-oxygen heterocycle |
| 01/23/2002 | EP1173170A1 Pyrrolidine modulators of chemokine receptor activity |
| 01/23/2002 | EP1173162A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/23/2002 | EP0902789B1 Androstene derivatives |
| 01/23/2002 | EP0884947A4 Dna vaccination for induction of suppressive t cell response |
| 01/23/2002 | EP0854711B1 gamma-RAR ANTAGONIST LIGAND OR alpha-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 01/23/2002 | EP0839046B1 Tnf receptor and steroid hormone dhea in a combined therapy |
| 01/23/2002 | EP0813539A4 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 01/23/2002 | EP0700445B1 Stress proteins and uses therefor |
| 01/23/2002 | CN1332847A Substance containing shiitake mushroom hypha extract for soreening lak activity and method for screening lak activity by using the same |
| 01/23/2002 | CN1332799A Cancer cell vaccine |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332741A Pyrazolopyridine derivatives as selective COX-2 inhibitors |
| 01/23/2002 | CN1332727A 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 01/23/2002 | CN1332711A Vitamin D analogues |
| 01/23/2002 | CN1332637A Preparations containing virus-like particles as immunopotentiators administered through mucosa |
| 01/23/2002 | CN1332634A Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 01/23/2002 | CN1332633A LAK activity potentiator orginating in shiitake mushroom hyphae extract and LAK activty potentiating preparations containing the same |
| 01/23/2002 | CN1332626A Inhalation system |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/22/2002 | US6340761 Amination and dehydrohalogenation with piperidine compounds |
| 01/22/2002 | US6340755 5H-Pyrano[2,3-d: 6,5-d']dipyrimidine derivatives having an antibacterial, antiviral and immuno-modulating activity |
| 01/22/2002 | US6340706 Antiinflammatory, antiallergic and antiproliferative agents |
| 01/22/2002 | US6340685 Antiinflammatory agents |
| 01/22/2002 | US6340684 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 01/22/2002 | US6340682 Diamide compound and drugs containing the same |
| 01/22/2002 | US6340681 Useful as analgesics in mammals |
| 01/22/2002 | US6340460 Therapeutic suppression of specific immune response by administration of oligomeric forms of antigen of controlled chemistry |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | CA2237971C Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 01/22/2002 | CA2082820C Derivatives of 6-aminooctahydroindolizinetriol |
| 01/22/2002 | CA2051460C Pharmaceutical compounds |
| 01/18/2002 | CA2353677A1 Use of at least one extract of at least one iris in a composition intended to stimulate immune defence |
| 01/17/2002 | WO2002004641A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004640A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004639A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004624A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004520A2 Transporters and ion channels |
| 01/17/2002 | WO2002004516A2 Use of the heat shock protein gp96 |
| 01/17/2002 | WO2002004514A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/17/2002 | WO2002004506A1 A new polypeptide- human rna binding protein 19 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004503A1 A new polypeptide- human l1 factor orf2 reverse transcription-related protein 15 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004502A1 A NEW POLYPEPTIDE- MURINE ZINC FINGER PROTEIN (Zfp-1)16 AND THE POLYNUCLEOTIDE ENCODING IT |
| 01/17/2002 | WO2002004500A1 A new polypeptide- human zinc finger protein fpm315-17 and the polynucleotide encoding it |
| 01/17/2002 | WO2002004499A1 Chemokine receptor modulators, production and use |
| 01/17/2002 | WO2002004490A2 Lipid metabolism molecules |
| 01/17/2002 | WO2002004472A1 Novel compounds and methods |
| 01/17/2002 | WO2002004459A1 Modulators of protein tyrosine phosphatases (ptpases) |
| 01/17/2002 | WO2002004434A1 Colchinol derivatives as vascular damaging agents |
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004426A1 Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists |
| 01/17/2002 | WO2002004424A1 Pyrazole derivatives |
| 01/17/2002 | WO2002004420A1 Piperidine coumpounds for use as ccr-3 inhibitors |
| 01/17/2002 | WO2002004019A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 01/17/2002 | WO2002004017A2 Method for preparing oral vaccines |
| 01/17/2002 | WO2002004015A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 01/17/2002 | WO2002004002A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 01/17/2002 | WO2002004000A1 Potent immunostimulants from microalgae |
| 01/17/2002 | WO2002003911A2 Prevention and treatment of alzheimer's disease |
| 01/17/2002 | WO2002003910A2 Antibacterial, antioxidant, immunomoduling and anticancerogenic preparation and method for using said preparation |
| 01/17/2002 | WO2002003813A1 Use of dammarane-type triterpenoid saponins |
| 01/17/2002 | WO2001062726A3 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 01/17/2002 | WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method |
| 01/17/2002 | WO2001055370A3 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES |
| 01/17/2002 | WO2001054672A3 Closure of bacterial ghosts |
| 01/17/2002 | WO2001049320A3 Use of hemicellulose microparticles as vaccine adjuvant |
| 01/17/2002 | WO2001047950A3 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 01/17/2002 | WO2001047922A3 Azaindoles |
| 01/17/2002 | WO2001047543A3 Activation and inhibition of the immune system |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | WO2001044448A3 Human oxidoreductase proteins |
| 01/17/2002 | WO2001041782A3 Method for administering a cytokine to the central nervous system and the lymphatic system |
| 01/17/2002 | WO2001038303A3 Vitamin d analogues |
| 01/17/2002 | WO2001037847A3 Nontoxic vernix compositions and method of producing |
| 01/17/2002 | WO2001032830A3 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom |
| 01/17/2002 | WO2001032696A3 Traf family proteins |
| 01/17/2002 | WO2001030362A3 Ribozyme therapy for the treatment of proliferative skin and eye diseases |
| 01/17/2002 | WO2001029078A3 Method for production and use of mite group 1 proteins |
| 01/17/2002 | WO2001027144A3 Ab5 toxin b subunit mutants with altered chemical conjugation characteristics |
| 01/17/2002 | WO2001022972A3 Immunostimulatory nucleic acids |
| 01/17/2002 | WO2001021161A3 Use of desloratadine for treating allergic and inflammatory conditions |
| 01/17/2002 | WO2001016293A3 Dna encoding the human serine protease t |
| 01/17/2002 | WO2001015710A3 A method of treatment of human immunodeficiency diseases |
| 01/17/2002 | WO2001012598A3 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 01/17/2002 | WO2001007471A3 Cell cycle and proliferation proteins |
| 01/17/2002 | WO2000078953A3 Human transport proteins |
| 01/17/2002 | WO2000078952A3 Human rna metabolism proteins (rmep) |
| 01/17/2002 | US20020007085 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 01/17/2002 | US20020007046 Polypeptides for use in the diagnosis, prevention and treatment of cancer and immunological defects |
| 01/17/2002 | US20020006951 Solid-state form of celecoxib having enhanced bioavailability |
| 01/17/2002 | US20020006945 Immunology diseases |